Phio Pharmaceuticals Corp. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Phio Pharmaceuticals Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $66K.
  • Phio Pharmaceuticals Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $193K.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2023 was -$2K, a 88.9% increase from 2022.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2022 was -$18K, a 108% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Nonoperating Income (Expense) for 2021 was $224K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.